Main Topic Area
All Topic Areas
1 - 10 of 65 more >>
Articles
1 - 5 of 9 more >>
- FDA Approves First New Drug Application for Treatment of Radiation Contamination due to Cesium or Thallium
This is a revised version of FDA Press Release P03-75, originally issued earlier on Oct. 2, 2003. Corrections were made to the original version, which is now obsolete. The Food and Drug Administration (FDA) today approved a New Drug Application for Radiogardase, also known as Prussian blue, to treat people exposed to radiation contamination, due to harmful levels of cesium-137 or thallium. Radiogardase capsules contain Ferric (III) hexacyanoferrate(II). The approval of Radiogardase is part of...
U.S. Food and Drug Administration
- Oral Complications of Chemotherapy and Radiation
This patient summary on oral complications of cancer and cancer therapy is adapted from the summary written for health professionals by cancer experts. This and other accurate, credible information about cancer treatment, screening, prevention, supportive care, and ongoing clinical trials is available from the National Cancer Institute. Oral complications are common in cancer patients, especially those with head and neck cancer. This summary describes oral complications caused by chemotherapy...
National Cancer Institute
- Animal Studies Show Promise Treating Severe Chronic Pain
Researchers may be on the trail of a new and more targeted treatment for severe chronic pain. In the current issue of the Journal of Clinical Investigation, a team of scientists established in a series of animal studies the therapeutic potential of selectively deleting specific nerve cells from the nervous system that convey severe chronic pain. So effective was the treatment in eight dogs severely affected by osteroarthritis, cancer-related pain, or both, all eventually became more active and...
National Institutes of Health
- Radiation Therapy for Cancer: Questions and Answers
Key Points Radiation therapy uses ionizing radiation to kill cancer cells and shrink tumors (see Question 1). About half of all people with cancer are treated with radiation therapy, either alone or in combination with other types of cancer treatment (see Question 1). Radiation therapy may be external or internal. External radiation, the type most often used, comes from a machine outside the body, and is usually given on an outpatient basis. Internal radiation is implanted into or near the...
- Cancer Studies at the NIH Clinical Center: Q and A
Key Points Everyone seen at the National Institutes of Health (NIH) Clinical Center is either being screened for or participating in a clinical trial (research study) (see Question 2). International patients can participate in clinical trials at the NIH Clinical Center if they meet the trial’s specific medical eligibility requirements (see Question 3). As part of the Federal Government, the NIH Clinical Center provides treatment at no cost to the patient (see Question 4). The Pediatric...
Organizations
1 - 5 of 12 more >>
- Office of Air and Radiation, EPA - http://www.epa.gov/oar/oarhome.html
- Radiation Therapy Oncology Group -
- Radiation Internal Dose Information Center - http://dwb.unl.edu/Teacher/NSF/C03/C03Links/www.orau.gov/ehsd/ridic.htm
- National Council on Radiation Protection and Measurements - http://www.ncrp.com/
- Environmental Protection Agency, Office of Air and Radiation -
News
1 - 5 of 2897 more >>
- Studies Examine Effects Of Circumcision, Hepatitis B Treatment On HIV/AIDS
MedicalNewsToday - Wed, 07 Mar 2007 03:00 EST
- Radiation for breast cancer ups heart disease risk
Reuters - Wed, 07 Mar 2007 03:09 EST
- New Details In Schizophrenia Treatment Trial Emerge
MedicalNewsToday - Wed, 07 Mar 2007 01:00 EST
- Breast Cancer Survivors Experience Long-term Heart Disease Risk From Radiotherapy
ScienceDaily - Wed, 07 Mar 2007 04:00 EST
- Incidence Of Benign Pathologic Findings At Partial Nephrectomy For Solitary Renal Mass Presumed To Be Renal Cell Carcinoma On Preoperative Imaging
MedicalNewsToday - Mon, 05 Mar 2007 08:00 EST
Clinical Trials
1 - 5 of 1710 more >>
- Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ
ClinicalTrials.gov Identifier: NCT00438659 - Active, not recruiting
Breast Cancer; Dermatologic Complications; Radiation Toxicity; Skin Reactions Secondary to Radiation Therapy
- Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy
ClinicalTrials.gov Identifier: NCT00540930 - Active, not recruiting
Uveal Melanoma; Radiation Retinopathy; Radiation Maculopathy
- Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
ClinicalTrials.gov Identifier: NCT00006994 - Active, not recruiting
lip and oral cavity cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer; Pain; radiation toxicity
- Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia
ClinicalTrials.gov Identifier: NCT00081029 - Recruiting
Hypopharyngeal Cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer; radiation toxicity
- Study of Markers of Cosmic Radiation Exposure and Effect Among Flight Crews
ClinicalTrials.gov Identifier: NCT00341900 - Active, not recruiting
Chromosomal Aberrations; Cosmic Radiation

Not Signed In -

